Evidence map›Paper›PMID 38020554›Full record

ArticleJournal of traditional and complementary medicine2023

Bhimashankar Utage, Milind Patole, Punam Nagvenkar, Rajesh Gacche

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of traditional and complementary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bhimashankar UtageNational Centre for Cell Science, NCCS Complex, Pune, 411007, MS, India.
Milind PatoleNational Centre for Cell Science, NCCS Complex, Pune, 411007, MS, India.
Punam NagvenkarNational Centre for Cell Science, NCCS Complex, Pune, 411007, MS, India.
Rajesh GaccheDepartment of Biotechnology, Savitribai Phule Pune University, Pune, 411007, MS, India.
National Centre for Cell Science · INSavitribai Phule Pune University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Leishmaniasis is endemic in more than 60 countries with a large number of mortality cases. The current chemotherapy approaches employed for managing the leishmaniasis is associated with severe side effects. Therefore there is a need to develop effective, safe, and cost affordable antileishmanial drug candidates. Purpose of the study: This study was designed to evaluate the Material and methods: PJLME was evaluated for its cytotoxicity against the Results: PJLME demonstrated antileishmanial activity at a remarkably lower concentration of IC Conclusion: The results clearly established the significance of

Indexed as

ApoptosisCell cycleGC-MSNatural productsProsopis julifloraVisceral leishmaniasis

Identifiers

PMID38020554
PMCPMC10658441
OpenAlexW4382602779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.